12.09.25 -- STREAM Edition: Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

Inadequate analytical development and process validation pose significant challenges for advanced therapies. Finding expert partners with the necessary skills to optimize AAV processes is crucial for minimizing variability and risk.

Expertise is critical for overcoming the unique challenges of autologous cell therapy manufacturing. Discover how experienced partners help reduce risk, streamline processes, and ensure quality from development through commercialization.

Advanced analytics and smart workflow design are transforming CHO medium and feed development. Learn how data-driven strategies improve consistency, scalability, and efficiency in biopharmaceutical manufacturing.

 

Downstream bioprocessing is critical for efficiency, scalability, and product quality in cell and gene therapy manufacturing. Explore innovative strategies and emerging technologies that reduce bottlenecks, improve yield, and streamline workflows for better outcomes.

Watch this detailed rundown of a novel, highly efficient method for accurately quantifying L-Citrulline, L-Arginine, and L-Argininosuccinic acid using Mitra tip extraction coupled with LC-MS/MS for enhanced precision, reproducibility, and streamlined workflows.

Unlock high yields in pluripotent stem cell expansion with innovative approaches. Assimilate how vertical-wheel bioreactors perform compared to traditional stir tank systems, offering advantages in passaging, feeding, harvesting, and maintaining cell quality.

Cyril Konto, CEO at Ichnos Glenmark Innovation, talks about the promise of multi-specific antibodies, funding the company during the 'biotech winter,' closing a $700 million upfront licensing deal with AbbVie, the impact of China's rising biotech sector, and the keys to collaboration.